CXCL10 and neoplasm: In cancers like pancreatic ductal adenocarcinoma, CXCL10-CXCR3 signaling maintains an inflammatory, anti-tumor M1 macrophage phenotype, and blockade of this axis promotes a shift to a tumor-supportive M2 phenotype [25].